Zotti S, Dagnini G, Abrahamsohn C, de Nadai Frank A, Sandri R
Minerva Med. 1977 Feb 11;68(7):431-7.
In most regimens proposed for the depletive management of cirrhosis of the liver, spirolactone is associated with other diuretics. Treatment of 28 patients with uncompensated forms by means of spirolactone only, using high, protracted doses determined essentially in accordance with the depletion obtained, is described. The disappearance of signs of water retention was gradual and unattended by difficulties. Normalisation of the urinary Na/K ratio preceded the diuretic response; Increased diuresis led to a slight increase in urinary potassium/day. Higher doses were used in patients with lower urinary Na/K ratios. Here a critical diuretic response was only obtained around the 5th day. Transient low blood sodium and chlorine and high blood potassium were noted; the last parameter was not related to the drug dose, nor to changes in Bun; No marked changes in blood uric acid, calcium, ammonium, bilirubin or sugar were observed.
在大多数针对肝硬化消耗性管理提出的治疗方案中,螺内酯与其他利尿剂联合使用。本文描述了仅使用螺内酯对28例失代偿期患者进行治疗的情况,使用的高剂量且疗程长,剂量主要根据所获得的脱水量来确定。水潴留体征的消失是渐进的,且未出现困难情况。利尿反应之前尿钠/钾比值已恢复正常;尿量增加导致每日尿钾略有增加。尿钠/钾比值较低的患者使用了更高剂量。在此情况下,仅在第5天左右才出现明显的利尿反应。观察到短暂的低血钠、低血氯和高血钾;最后一个参数与药物剂量无关,也与血尿素氮的变化无关;未观察到血尿酸、血钙、血铵、胆红素或血糖有明显变化。